Nuformix

(NFX)
Sector: Pharmaceuticals & Biotechnology
0.04p
-0.01p -14.89
Last updated: 11:56:47

Director dealings

Trade date Director Volume / Price Trade value Trade type
05/11/2024 Daniel Gooding 12,000,000 @ 0.05p £6,000.00 Buy
05/11/2024 Madeleine Kennedy 22,000,000 @ 0.05p £11,000.00 Buy
05/11/2024 Julian Gilbert 22,000,000 @ 0.05p £11,000.00 Buy
10/01/2022 Alastair James Riddell 400,000 @ 1.18p £4,720.00 Buy
16/09/2021 Alastair James Riddell 350,000 @ 1.35p £4,725.00 Buy
30/03/2021 Joanne Holland 0 @ 0.00 0.00 Notification of Holding
04/02/2020 David Tapolczay 0 @ 0.00 0.00 Notification of Holding
24/01/2020 David Tapolczay 650,000 @ 8.70p £56,550.00 Sell
16/08/2018 Kirk Siderman-Wolte 35,364 @ 2.60p £919.46 Buy
31/03/2018 Daniel Gooding 0 @ 0.00 0.00 Notification of Holding
31/03/2018 Joanne Holland 0 @ 0.00 0.00 Notification of Holding
31/03/2018 David Tapolczay 0 @ 0.00 0.00 Notification of Holding
17/12/2015 John Lidgey 0 @ 0.00 0.00 Notification of Holding
17/12/2015 Pascal Hughes 0 @ 0.00 0.00 Notification of Holding
17/12/2015 Anthony H Reeves 0 @ 0.00 0.00 Notification of Holding

Director shareholdings

Name Holding Percent
Daniel Gooding 49,500,000 0.00%
Julian Gilbert 22,250,000 0.00%
Madeleine Kennedy 22,250,000 0.00%

Major shareholders

Institution name Holding Percent
Hargreaves Lansdown (Nominees) Limited 120,122,084 24.51%
Centre for Process Innovation Limited 62,700,000 13.61%
Vidacos Nominees Limited 51,252,063 10.46%
JIM Nominees Limited 50,977,205 10.40%
HSDL Nominees Limited 37,756,993 7.70%
Daniel Gooding 37,500,000 5.29%
Joanne Holland 37,500,000 5.29%
Barclays Direct Investing Nominees Limited 27,406,547 5.59%
Novum Securities Limited 22,500,000 4.88%
Raymond James Investment Services Limited 22,500,000 4.88%
Spreadex Ltd 16,818,894 3.58%
Rampart Management Limited 8,600,000 8.98%
Ambeson Limited 6,500,000 6.79%
GB Trust Co Limited 6,100,000 6.37%
OBB Trading Limited 4,650,000 4.86%
Martin-Dreyer 3,750,000 3.92%
Ian Burton 3,000,000 3.13%
Kathy Steffen 2,950,000 3.08%